PATENT CLAIM ANALYSIS

Application Number: 15905711
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "174100"]

Abstract:
The present invention relates to the field of molecular biology and cancer biology. Specifically, the present invention relates to methods of treating a subject with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on genotyping and expression profiling of certain immunological genes and RAS mutation status in the subject.

Claim (Index 25):
The method of  claim 24 , wherein said second active agent is selected from the group consisting of gemcitabine, cisplatin, carboplatin, and docetaxel.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 88.0
- Lexical Diversity: 1.43478
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15346675', '15844478', '15238458', '15820012', '15820157']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8630436273202997
- 35 USC 102 Novelty (BERT): 0.6083467235123559
- Combined Prediction Score: 0.8375739369395054
- Mean Citation Score: 582.25276
- Max Citation Score: 745.21075
- Similarity Product: 471.0807517073452

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test